Cargando…
YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells
BACKGROUND: The brain cancer stem cell (CSC) model describes a small subset of glioma cells as being responsible for tumor initiation, conferring therapy resistance and tumor recurrence. In brain CSC, the PI3-K/AKT and the RAS/mitogen activated protein kinase (MAPK) pathways are found to be activate...
Autores principales: | Mantwill, Klaus, Naumann, Ulrike, Seznec, Janina, Girbinger, Vroni, Lage, Hermann, Surowiak, Pawel, Beier, Dagmar, Mittelbronn, Michel, Schlegel, Jürgen, Holm, Per Sonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848904/ https://www.ncbi.nlm.nih.gov/pubmed/24044901 http://dx.doi.org/10.1186/1479-5876-11-216 |
Ejemplares similares
-
Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021) -
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
por: Koch, Jana, et al.
Publicado: (2022) -
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model
por: Klawitter, Moritz, et al.
Publicado: (2022) -
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice
por: El-Ayoubi, Ali, et al.
Publicado: (2023) -
Microarray Analysis in a Cell Death Resistant Glioma Cell Line to Identify Signaling Pathways and Novel Genes Controlling Resistance and Malignancy
por: Seznec, Janina, et al.
Publicado: (2011)